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CONTACT DERMATITIS
Reactivity of in vitro activated human T lymphocytes
to p-phenylenediamine and related substances
CLAUDIA SKAZIK1,2,*,†, SILKE GRANNEMANN2,†, LIANE WILBERS1, HANS F. MERK1, PIETER-JAN COENRAADS3,
SEBASTIAN BREUER2 AND BRUNHILDE BLO¨MEKE2
1Department of Dermatology and Allergology, University Hospital of the RWTH Aachen, 52074 Aachen,
2Department of Environmental Toxicology, University of Trier, 54296 Trier, Germany, and 3Department of
Dermatology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, the Netherlands
Background: Patch tests to p-phenylenediamine (PPD) and related substances often show concurrent
reactions that can be attributed to separate sensitization or cross-reactivity.
Objectives: In order to understand the health risks associated with cross-reactivity, we studied cross-
reactivity of eight chemicals in vitro by measurement of T-cell proliferation of peripheral blood
mononuclear cells (PBMC), T-cell lines (TCL), and T-cell clones (TCC) of subjects with a positive
patch test result to PPD.
Patients/Methods: We studied PBMC from 13 patients and were able to generate TCL from seven
and TCC from four patients. Their proliferative responses to the chemicals were estimated.
Results: Concurrent reactions to these compounds on the polyclonal and monoclonal level were
found. A restricted T-cell receptor (TCR) Vb16-usage was observed (5/8 clones). A detailed analysis
of 34 TCL showed broad cross-reactivity (64.7%) between PPD, p-toluenediamine, Bandrowski’s
Base, and p-aminoazobenzene. More restricted patterns were found in 8.8%, which responded only
to compounds with two or three benzene rings, whereas 26.5% of the clones reacted specifically only
to one compound.
Conclusion: More than 60% of the clones showed a broad cross-reactivity pattern. Hence, clinically
observed cross-reactivity between different para-amino compounds can be based on a TCR recog-
nizing similar epitopes of these compounds with low specificity.
Keywords: cross-reaction; delayed-typehypersensitivity;para-aminocompounds;p-phenylenediamine;
T-cell clones; Vb analysis. # Blackwell Munksgaard, 2008.
Accepted for publication 13 May 2008
Allergic contact dermatitis, a delayed hypersensitiv-
ity reaction to small molecular weight compounds
(haptens), is a common skin reaction causing
personal and occupational problems (1, 2). Chem-
icals such as p-phenylenediamine (PPD) and re-
lated para-amino compounds, frequently found in
dyes, are raising increasing concerns due to their
strong allergenicity. Recent surveys in Europe,
USA and Japan indicate that hair dyeing and
skin paintings have become much more prevalent
during the past 10 years; it is performed at a youn-
ger age and the proportion of men is increasing
(3). Thus, contact allergy to PPD and related
compounds has increased significantly in eczema
patients (3, 4) and also in the general population
(5) over the past decades.
So far, the mechanism of skin sensitization and
elicitation to the pro- or prehapten PPD (6) has
not been elucidated, but some hypotheses on the
sensitization to small chemicals exist. The hapten
concept (7) suggests that small chemically reac-
tive compounds, which are not immunogenic by
*Present address: Department of Dermatology and
Allergology, University Hospital of the RWTH
Aachen, Pauwelsstr. 30, 52074 Aachen, Germany
†These authors contributed equally to this work.
themselves, bind to proteins or peptides and mod-
ify them. The modified proteins are processed and
presented as hapten-modified peptides in associa-
tion with human leucocyte antigen molecules to
T cells and are able to activate them (8, 9). Hapt-
ens are often derived from chemicals considered as
prohaptens, which are not chemically reactive per
se and have to be metabolized into an electrophilic
hapten endowed with antigenic properties first
(10, 11). Moreover, it has been recently reported
that chemically inert substances can bind directly
to the major histocompatibility complex (MHC)–
peptide complex in a processing-independent way
and thus can interact with the T-cell receptor
(TCR) and stimulate T cells (12). We found data
supporting this concept while studying the contact
allergen PPD (13) showing that PPD can activate
memory T cells using glutaraldehyde-fixed anti-
gen-presenting cells (APC) that are incapable of
processing. Based on this context, it is supposed
that the cross-reactivity of structurally related
compounds depends on the affinity, concentra-
tion, andTCRdensity expressed on the cell surface
(14). Different mechanisms have been assumed to
account for frequently observed cross-reactivity to
haptens: generation of a common reactive metab-
olite that acts as a hapten, the T cell would then
recognize identical neoantigens, T-cell recognition
of cryptic self-peptides, or true cross-reactions,
whereas the TCR of a T cell is incapable to distin-
guish between the different haptens (15). Further-
more, some evidence indicates that the concomitant
reactions to PPD and textile dyes (16) may also be
due to metabolic conversion of dyes to PPD at the
surface by skin bacteria (17).
In patients with positive patch tests to PPD,
high frequencies of simultaneous sensitivity (16,
18, 19) of memory T cells to p-toluenediamine
(PTD), para-aminoazobenzene (AAB), and also
azo dyes used in textiles, like Disperse Orange 3
(DO3), Disperse Yellow 3 (DY3), and Disperse
Blue (DB 106/124), or Bandrowski’s Base (BB)
(20), an autoxidation product of PPD (21), have
been diagnosed.
Hence, to be able to estimate and decrease the
health risks associated with exposure to these
substances, it is important to understand the
mechanism of cross-reactivity to different para-
amino compounds. In order to analyse T-cell
cross-reactivity to para-amino compounds such
as PTD, BB, AAB, DO3, 4,49-diaminodiphenyl-
methane (DDM), Bismarck Brown Y (BBY), and
DY3, and the unrelated contact allergen mercap-
tobenzothiazole (MBT) (Fig. 1) in humans, we
investigated in vitro T-lymphocyte responses from
PPD-positive cases in polyclonal and monoclonal
T-cell subsets such as peripheral blood mononu-




We investigated 13 subjects (10 females and 3
males; 11 tested with the German patch test base-
line series and 2 with the Dutch standard series)
showing at least þþ positive patch test reactions
to PPD according to the International Contact
Dermatitis Research Group’s recommendations
(application period: 2 days; readings at 2, 3, and
7 days) and a strong history of allergic contact der-
matitis due to personal (hair dyeing and tattoo) or
occupational exposure (hairdresser) to PPD. The
study was approved by the local ethics committee,
and all subjects gave informed consent. Patch test
materials were purchased from Hermal (Reinbek,
Germany) (1% in petrolatum) and applied in Finn
chambers (Epitest Ltd Oy, Tuusula, Finland).
Antigens
PPD (freebase), AAB, DO3, DY3, DDM, BBY,
and 2-MBT were obtained from Sigma (Stein-
heim, Germany). BB was purchased from INC
Biomedicals (Aurora, OH, USA) and PTD from
Merck (Hohenbrunn, Germany). Stock solutions
of each antigen were prepared freshly in culture
medium by using light-protected tubes to avoid
unspecific effects. The non-toxic antigen concen-
tration was determined as concentration that did
not affect phytohaemagglutinin (PHA)-induced
proliferation of PBMC as described earlier (22).
The purity of PPD and PTD was 98%, AAB was
98.9% and DDM and MBT was 99% or more
based on the information given by the companies.
The manufacturers of BB, DO3, DY3, and BBY
did not provide the purity but provided informa-
tion on the melting point and lmax or thin layer
chromatography comparisons of the product with
standards. We used the same substances as are
commonly used in patch tests, although we are
aware of the existing differences in purity (23).
Culture medium
The cell culture medium used in this study was
RPMI-1640 supplemented with L-glutamine, 10%
foetal calf serum (FCS) (PAA, Pasching, Austria),
1%100 mMsodiumpyruvate, 1%10non-essential
amino acids, and 1% antibiotic-antimycotic solu-
tion (Gibco BRL, Paisley, Scotland).
For growing TCL and TCC, the complete
culture medium was prepared without any
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antibiotics, but with the addition of 2% heat-
inactivated pooled human AB serum (Sigma).
Proliferation assays
PBMC were isolated by density centrifugation
over Ficoll-Paque (Uppsala, Sweden). Antigen-
specific proliferation was investigated by cultur-
ing (37C, 5% CO2) PBMC alone (2  105 cells),
TCL, or TCC (1  105 cells) plus autologous
gamma-irradiated PBMC (2.5  105 cells) in
the presence and absence of antigen (1–50 mM
in order to avoid toxicity for PBMC, data not
shown), 4.25 Lf/ml tetanus toxoid (TT) as control
for specificity, and PHA as a mitogenic control in
a total volume of 200 ml (96-well plates with flat
bottom; Falcon BD, Cedex, France). After two
(TCL and TCC) or 6 days (PBMC), cultures were
pulsed with [3H]thymidine (0.5 mCi) and incu-
bated for additional 16 hr. Cells were harvested
on a glass fibre filter, and the [3H]thymidine in-
corporation was measured as counts per minute
(c.p.m.) using aWallacMicroBeta Counter (Perkin
Elmer, Zaventem, Belgium). Stimulation indexes
(SI) were calculated as c.p.m. in the presence of
a compound (antigen) divided by c.p.m. in the
absence of compound (mean c.p.m.  SD of tripli-
cate cultures). SIof greater than2.0were considered
as significant responses.
Generation of TCC
TCC were generated using the limiting dilution
technique as described (13). Briefly, chemical-
specific TCL (PTD, BB or PPD, and only a few
with AAB or BBY) were diluted to a cell density of
0.5 cell/well and cultured in 96-well round-bottom
culture plates with 4  105 autologous-irradiated
Fig. 1. Chemical structures of the
investigated compounds.
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PBMC in the presence of antigen and interleukin
(IL)-2 (50 U/ml; Endogen, Woburn, MA, USA)
in complete culture medium (10% FCS and 2%
pooled human AB serum). Growing TCC were
maintained in complete culture medium by peri-
odic restimulation in the presence of irradiated
PBMC, antigen, and IL-2. The specificity was
tested as described above.
Flow cytometric analysis
Aliquots that contained 105 cells were stained with
fluorochrome conjugated antibodies in 50 ml of
buffer (phosphate-buffered saline with 1% FCS
and 0.02% NaN3) for 30 min at 4C and analysed
on a FACSCalibur flow cytometer (BD Bioscien-
ces, Heidelberg, Germany). Anti-CD3 (HIT3a,
mIgG2a), anti-CD8 (HIT8a, mIgG1), anti-CD4
(RPA-T4, mIgG1), anti-CD45RA (HI100,
mIgG2b), and anti-CD45RO (UCHL1, mIgG2a)
were purchased from BD Biosciences. TCR-Vb
expression of TCC was analysed by staining us-
ing a panel of 24 monoclonal antibodies against
various Vb gene products (DPC Biermann, Bad
Nauheim, Germany): Anti-TCR-ab (BMA031,
mIgG2b), anti-TCR-gd (Immu510, mIgG1),
anti-Vb1 (BL37.2, rIgG1), anti-Vb2 (mIgG1),
anti-Vb3 (CH92, mIgM), anti-Vb5.1 (3D11,
mIgG1), anti-Vb5.2 (36213, mIgG1), anti-Vb5.3
(3D11, mIgG1), anti-Vb7 (ZOE, mIgG2a), anti-
Vb8.1/8.2 (56C5, mIgG2a), anti-Vb9 (FIN9,
mIgG2a), anti-Vb11 (C21, MigG2a), anti-Vb12
(Ver2.32.1, MigG2a), anti-Vb13.1 (Immu222,
mIgG2b), anti-Vb13.6 (JU-74, mIgG1), anti-Vb14
(CAS1.1.3, mIgG1), anti-Vb16 (TAMAYA1.2,
mIgG1), anti-Vb17 (E17.5F3, mIgG1), anti-Vb18
(BA62, mIgG1), anti-Vb20 (ELL1.4, mIgG1), anti-
Vb21.3 (IG125, mIgG2a), anti-Vb22 (Immu546,
mIgG1), and anti-Vb23 (AF-23, mIgG1).
Results
T-cell responses to para-amino compounds
including some azo dyes were characterized using
PBMC of 10 females and 3 males (mean age ¼ 50
years, range: 26–93) based on at leastþþ positive
patch test reactions to PPD and a history of aller-
gic contact dermatitis due to personal or occupa-
tional exposures. Specific proliferative responses
of PBMC to PPD were observed in 11 cases
(SI ¼ 2.2–49.3; Table 1). No associations with
sex and age were observed. Thus, we found a good
correlation (83%) between our in vitro results and
the in vivo test.
Further proliferation studies on the polyclonal
level found similar SI (2.1–49.3) for BB, PTD,
AAB, DO3, DDM, and BBY as classical para-
amino compounds (Figs 1 and 2) and azo dye
DY3. There was also a similar SI for MBT as
a contact allergen that does not belong to any of
Fig. 2. Proliferative responses (c.p.m.) of PBMC (6 days)
and TCL (2–3 days) from 11 PPD-sensitized persons to dif-
ferent para-amino compounds/arylamines (1–50 mM) and the
chemically unrelated MBT. Antigen-specific T-cell prolifera-
tion was measured by [3H]thymidine incorporation assay. In
this graph, the results are shown as proliferation after sub-
traction of control without antigen (PBMC: 575–175375
c.p.m. and TCL: 520–52760 c.p.m.). Only results with SI > 2
are depicted (PBMC: 2.1–49.3 SI; TCL: 2.1–24.6 SI). TT-
specific responses served as positive control for T-cell func-
tionality, finding lower responses in TCL compared with
PBMC because antigen-specific T cells accumulate during
restimulation. For this reason, positive TT data in this figure
derive from PBMC only.
AAB, p-aminoazobenzene; BB, Bandrowski’s Base; BBY,
Bismarck Brown Y; c.p.m., counts per minute; DDM, diami-
nodiphenylmethane; DO3, Disperse Orange; DY3, Disperse
Yellow; MBT, mercaptobenzothiazole; PBMC, peripheral
blood mononuclear cells; PPD, p-phenylenediamine; PTD,
p-toluenediamine; SI, stimulation indices; TT, tetanus toxoid.
Table 1. Comparison of the patch test results and in vitro pro-



















PPD, p-phenylenediamine; SI, stimulation indices.
aPatch test readings were taken at D2, D3, andD7 after exposure.
bPeripheral blood mononuclear cells were cultured with concen-
trations between 1 mM and 50 mM of PPD for 6 days and the
proliferative responses were measured by [3H]thymidine incor-
poration assay. Positive reactions were defined as SI > 2 only the
highest indices are presented.
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the mentioned chemical groups. Antigen concen-
trations between 1 mM and 50 mM were applied.
TT-specific responses served as positive control
for T-cell functionality, finding as expected lower
responses in TCL compared with PBMC, because
antigen-specific T cells accumulate during restim-
ulation. For this reason, positive TT data in Fig. 2
derive from PBMC only.
Overall, on the polyclonal level, most concom-
itant reactions to PPD arose for AAB (92%) fol-
lowed by DO3 (85%). Furthermore, we found
co-reactions to BB (69%), DDM (62%), DY3
(54%), BBY (46%), PTD (39%), and MBT (23%).
These in vitro results confirmed earlier clinical
observations and patch-testing studies in PPD-
sensitized subjects that display reactions to more
than just one substance.
In order to validate our findings on the mono-
clonal level, we aimed for generation of TCC from
all PPD-allergic persons by restimulation of their
PBMCwith different antigens, mainly PPD, PTD,
DO3, AAB, and BB. Overall, 35 TCC from four
subjects were successfully generated by limiting
dilution. TT was used as control for cloning suc-
cess, finding no responses in specific TCC. More-
over, we only included TCC that showed no
reaction to MBT in further experiments (n ¼ 34)
because MBT is structurally not related to the
other tested substances and no cross-reactions
with para-amino compounds are expected. Nine
TCC were additionally tested for reactions to ben-
zoquinone and did not react to this compound
(data not shown). A subgroup of 18 TCC was
analysed by flow cytometry (fluorescence-acti-
vated cell sorter). The tested clones were CD4 pos-
itive and expressed TCR-ab (Fig. 3) except one
TCC that was CD8 positive and expressed TCR-
gd. Unfortunately, we were not able to culture this
clone long enough for a detailed functional ana-
lysis. Further Vb chain analysis of eight TCC
showed a strong expression (>90%) of one Vb
chain and a restricted TCR-Vb usage, indicating
the oligoclonality of the dye-specific immune
response (Table 2). Interestingly, five of eight
TCC were positive for Vb16 (62.5%).
A summary of the TCC responses to the com-
pounds (SI ¼ 2–62, n ¼ 190) is depicted in Fig. 4,
whereas antigen concentrations between 1 mM and
50 mM were applied. Surprisingly, the pattern was
comparable to our findings on the polyclonal
level. Against the overall idea that one clone reacts
to one specific antigen, we found that the TCC
Fig. 3. Characterization of the generated T-cell clones through flow cytometry. (a) untagged, (b) CD4þ T lymphocytes,
(c) expressed T-cell receptor-ab, and (d) CD45RO accordingly representing memory T cells.
Contact Dermatitis 2008: 59: 203–211 CROSS-REACTIVITY TO PARA-AMINO COMPOUNDS 207
reacted to several of the tested related antigens
independent of the antigens they were generated
with. Therefore, in the context of our research
question, we defined ‘antigen specific’ as the pro-
liferative response of a TCC with a specific reac-
tion pattern to one or more antigens.
In a subset of five TCC, we examined the occur-
rence of concomitant reactions to PPD. All nine
substances were tested and most reactions besides
PPDwere found for AAB, DO3, PTD (three of five
TCC), and BB (two of five TCC). Only one co-
reaction was found for DY and DDM and no
responses occurred to BBY and MBT. First, we
concentrated further studies on PPD, PTD, BB,
and AAB and tested 34 TCC for cross-reactions.
Beside PPD and its autoxidation product BB, we
included PTD because of its structural similarity to
PPD, andAAB,which exhibits only one free amino
group (Fig. 1). The results lead to the identification
of certain reaction patterns: group I (26.5%, 9)
reacting specifically only to one antigen, group II
(64.7%, 22) reacted to compounds with one as well
as two or three benzene rings, and group III (8.8%,
3) TCC responded only to compounds with two
or three benzene rings. Hence, the following fre-
quency distribution arose: group II > group I >
group III. Secondly, we tested the validity of these
groups in 21 TCC and included two textile dyes
DO3 and BBY (Fig. 5). DO3 differs from AAB
only concerning one amino group; BBY was cho-
sen because it consists of three benzene rings like
BB, but in addition contains two azo groups
(Fig. 1). We validated our initial findings and even
the extension to nine tested antigens had no effect
on the grouping (data not shown). Moreover, inde-
pendent evaluation by considering responses only
with a stimulation index of SI  3 instead of 2
did not change the results. These results confirm
and extend our previous results showing that
PPD-specific monoclonal T cells can clearly
respond to several related para-amino compounds.
Discussion
Concomitant positive reactions to PPD and other
arylamines, para-amino compounds, and some
azo dyes are frequently reported in patch test stud-
ies. Theoretically, concomitant reactions can be
explained by concomitant sensitization or by
true cross-reactions (18, 24, 25). In addition, in
the case of azo dyes, simultaneous reactions may
result from metabolic conversion of dyes to the
corresponding monomers (17, 26). Furthermore,
early cross-reactivity analysis in inbred guinea-
pigs indicates that the recognizing ability of
hapten-specific lymphocytes varies according to
the position of the functional group and its type
(27). Thus, the aim of this study was to explore
concomitant reactions and cross-reactivity pat-
terns among PPD and para-amino compounds
in vitro. We tested whether PPD-specific T cells
also reacted to BB, PTD, AAB, DO3 (Fig. 1) on
the polyclonal (PBMC and TCL) and monoclonal
T cell level in order to better understand if this
finding is due to cross-reactions or simply due to
co-sensitization.
We found that all substances showed concomi-
tant reactions to PPD, basically confirming in vivo
patch test data. Seidenari et al. (18) showed in
patch tests highest concomitant reactions to PPD
for AAB (75%) and DO3 (66%). We observed
Fig. 4. Proliferative responses (c.p.m.) of arylamine-specific
TCC from PPD-sensitized persons to various para-amino
compounds/arylamines (1–50 mM). Antigen-specific T-cell
proliferation was measured after 2 days by [3H]thymidine
incorporation. In this graph, the results are shown as pro-
liferation after subtraction of control without antigen (c.p.m.
¼ 960–64050). Only results with SI > 2 are depicted (SI
¼ 2.1–62). TT served as control for cloning success, finding
no responses in specific TCC. Overall, the pattern of TCC
reactivity was similar to the polyclonal level but, as expected,
the clones did not react to the unrelated MBT. The one TCC
that reacted to MBT was excluded from further analysis.
AAB, para-aminoazobenzene; BB, Bandrowski’s Base;
BBY, Bismarck Brown Y; c.p.m., counts per minute;
DDM, diaminodiphenylmethane; DO3, Disperse Orange;
DY3, Disperse Yellow; MBT, mercaptobenzothiazole;
PPD,p-phenylenediamine;PTD,p-toluenediamine; SI, stimu-
lation indices; TCC, T-cell clones; TT, tetanus toxoid.
Table 2. Vb chain expression in a subset of the generated TCC
(n ¼ 8) estimated by flow cytometric analysis. In total, 21 Vb
chains were analysed
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in vitro on the polyclonal level the highest correla-
tion rates between positive reponses to PPD and
AAB (92%) respectively DO3 (85%), too. How-
ever, we cannot confirm other patch test studies
noticing that the stronger a patient reacts to PPD,
the higher is the probability for further reactions
to different substances (28).
In our study, BB, DDM, DY3, and BBY like-
wise showed various parallel reactions to PPD,
whereas in patch tests, no concomitant responses
to BBY were found in one study (16). Further-
more, this in vitro study found similar to others
(29) concomitant responses for BB (69%), while
only 16% of PPD-positive cases were positive to
BB by patch testing even when PPD reactions
were strong (20). This discrepancy may indicate
different bioavailability.
To provide further laboratory evidence of the
immune pathogenesis of allergic contact dermatitis,
we cloned arylamine-specific T cells from the peri-
pheral bloodofPPD-sensitive patients andanalysed
their phenotype, specificity in vitro, and the require-
ments of TCR activation by stimulating clones with
up to eight structurally related compounds.
We found that monoclonal T cells can be activa-
ted by various para-amino compounds similar to
the pattern found in polyclonal cultures (compare
Figs 2 and 4). Some TCC showed very specific
reactions to only one substance, but most TCC
displayed responses to more than one antigen.
Usually, antigens are presented in the context
of MHC expressed on the surface of APC, but
some chemicals for instance isopentenyl pyro-
phosphate and fluorescein can activate T cells
Fig. 5. Distinct proliferation patterns of representative TCC (n ¼ 21) from PPD-sensitized persons divided into three groups:
group I specific reaction to only one antigen (n ¼ 6); group II reactions to compounds with one and more benzene rings
(n ¼ 12) and group III reactions to antigens with two and more benzene rings (n ¼ 3). Cells were cultured in vitro with the
different para-amino compounds for 2 days. Afterwards, T-cell responses were measured by [3H]thymidine incorporation
assay. The line in the graph indicates stimulation indices ¼ 2, threshold for positive responses. TT served as control for cloning
success.
AAB, p-aminoazobenzenes; BB, Bandrowski’s Base; BBY, Bismarck Brown Y; DO3, Disperse Orange; PPD, p-phenylenedi-
amine; PTD, p-toluenediamine; TCC, T-cell clones; TT, tetanus toxoid.
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without the involvement of MHC molecules
through a TCR-dependent process (30, 31). In
addition, some drugs are able to elicit hypersensi-
tivity reactions without evidence for metabolism
or covalent binding to a carrier protein (32, 12).
Furthermore, for these drugs, the kinetics of TCR
downregulation is too fast for the involvement of
antigen processing. Due to these aspects, an addi-
tional model was proposed, referred as ‘pharma-
cological interaction of drugs with immune
receptors’ (p-i concept) (33). The idea is that some
chemicals bind reversibly to immune receptors
like MHC or TCR thereby stimulating T cells.
However, we found no proliferation when TCC
were incubated with the substances in the absence
of APC. These data indicate that our isolated
TCC do not present para-amino compounds to
each other. Interestingly, we found a restricted
usage of Vb chains in the arylamine-specific
CD4þ TCC, predominantly Vb16, exactly as
found earlier (13) This finding suggests that the
Vb16 chain plays an important role in the recog-
nition of para-amino compounds, although fur-
ther studies are required. So far, no comparable
data are available for PPD, but for nickel-specific
CD4þ T cells, it has been suggested that Vb17 is
involved in antigen recognition and possibly
severity of disease (34,35).
With the gathered data, we identified three
types of TCC. This grouping was valid in tests
with four, six, or nine substances and was also
found on the polyclonal level. This proves the
grouping to be no in vitro artefact and not to be
restricted to in vitro-generated TCC. The com-
pounds we used in our study consist of prohapt-
ens, so that it is possible that these substances are
presented to a TCC through different pathways
including the p-i concept (reviewed in 33). It is
conceivable that both pathways, with and without
antigen processing, are involved in the antigen
presentation of the tested arylamines, but more
detailed investigations are warranted.
Overall, for eachmolecule, activity and potential
to give rise to cross-reactions in vivowill depend on
skin penetration capacities including resorption,
and the balance between routes of individual skin
metabolism. The latter may also account for the
discrepancy between in vitro and in vivo findings
for BB in humans as described above.
In summary, the para-group allergy is charac-
terized in vitro by three types of specific CD4þ T
cells, while in vivo also CD8þ T cells play an im-
portant role. The majority (>60%) of the CD4þ T
cells bears a TCR with minor specificity. T cells
with a low specificity TCR likely account for the
in vivo observed cross-reactions between related
chemicals. Our observed broad cross-reactivity
pattern suggests an explanation for the in vivo
observed predisposition to immune reactivity after
a single exposure to related compounds.
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